D.H.E. 45 (Valeant Pharmaceuticals North America)


Welcome to the PulseAid listing for the D.H.E. 45 drug offered from Valeant Pharmaceuticals North America. This Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America
NON-PROPRIETARY NAME: Dihydroergotamine Mesylate
SUBSTANCE NAME: DIHYDROERGOTAMINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2001-10-03
END MARKETING DATE: 0000-00-00


D.H.E. 45 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionD.H.E. 45 from Valeant Pharmaceuticals North America
LABELER NAME: Valeant Pharmaceuticals North America
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2001-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66490-041_e5d790c0-7211-46d7-bde6-ddb4130888d3
PRODUCT NDC: 66490-041
APPLICATION NUMBER: NDA005929

Other DIHYDROERGOTAMINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Oceanside PharmaceuticalsDihydroergotamine Mesylate
Paddock Laboratories, LLCDihydroergotamine Mesylate
Valeant Pharmaceuticals North AmericaD.H.E. 45
Valeant Pharmaceuticals North America LLCMigranal
West-Ward Pharmaceuticals CorpDihydroergotamine Mesylate